Interferon-induced antiviral actions and their regulation - PubMed (original) (raw)

Review

Interferon-induced antiviral actions and their regulation

G C Sen et al. Adv Virus Res. 1993.

No abstract available

PubMed Disclaimer

Similar articles

• Antiviral and antiproliferative properties of interferons: mechanism of action.
  Esteban M, Paez E. Esteban M, et al. Prog Med Virol. 1985;32:159-73. Prog Med Virol. 1985. PMID: 2410953 No abstract available.
• Viral inhibition of the interferon system.
  McNair AN, Kerr IM. McNair AN, et al. Pharmacol Ther. 1992;56(1):79-95. doi: 10.1016/0163-7258(92)90038-2. Pharmacol Ther. 1992. PMID: 1284285 Review.
• Interferons (IFNs) are key cytokines in both innate and adaptive antiviral immune responses--and viruses counteract IFN action.
  Bonjardim CA. Bonjardim CA. Microbes Infect. 2005 Mar;7(3):569-78. doi: 10.1016/j.micinf.2005.02.001. Epub 2005 Mar 3. Microbes Infect. 2005. PMID: 15792636 Review.
• [Mathematical model of regulation of biosynthesis and antiviral action of the interferon-induced protein Mx1].
  Bazhan SI, Belova OE. Bazhan SI, et al. Mol Biol (Mosk). 1997 Nov-Dec;31(6):1071-81. Mol Biol (Mosk). 1997. PMID: 9480421 Russian. No abstract available.
• Antiviral actions of interferon. Interferon-regulated cellular proteins and their surprisingly selective antiviral activities.
  Samuel CE. Samuel CE. Virology. 1991 Jul;183(1):1-11. doi: 10.1016/0042-6822(91)90112-o. Virology. 1991. PMID: 1711253 Review.

Cited by

• NS2 is a key determinant of compatibility in reassortant avian influenza virus with heterologous H7N9-derived NS segment.
  Liu YC, Liao GR, Tsai AY, Tseng CY, Kuan CY, Tsai RS, Albrecht RA, Kuo RL, Cheng IC, Liang WT, Ou SC, Hsu WL. Liu YC, et al. Virus Res. 2023 Jan 15;324:199028. doi: 10.1016/j.virusres.2022.199028. Epub 2022 Dec 23. Virus Res. 2023. PMID: 36572153 Free PMC article.
• Disruption of type I interferon signaling causes sexually dimorphic dysregulation of anti-viral cytokines.
  Darzianiazizi M, Allison KE, Kulkarni RR, Sharif S, Karimi K, Bridle BW. Darzianiazizi M, et al. Cytokine X. 2021 Jun 6;3(2):100053. doi: 10.1016/j.cytox.2021.100053. eCollection 2021 Jun. Cytokine X. 2021. PMID: 34189454 Free PMC article.
• Decreased expression of type I (IFN-β) and type III (IFN-λ) interferons and interferon-stimulated genes in patients with chronic rhinosinusitis with and without nasal polyps.
  Hwang JW, Lee KJ, Choi IH, Han HM, Kim TH, Lee SH. Hwang JW, et al. J Allergy Clin Immunol. 2019 Dec;144(6):1551-1565.e2. doi: 10.1016/j.jaci.2019.08.010. Epub 2019 Aug 23. J Allergy Clin Immunol. 2019. PMID: 31449915 Free PMC article. Clinical Trial.
• Baseline Hepatic Levels of miR-29b and Claudin are Respectively Associated with the Stage of Fibrosis and HCV RNA in Hepatitis C.
  Sendi H, Mehrab-Mohseni M, Russo MW, Steuerwald N, Jacobs C, Clemens MG, Bonkovsky HL. Sendi H, et al. Clin Exp Gastroenterol Hepatol. 2019 Jan-May;1(1):105. Epub 2019 Mar 8. Clin Exp Gastroenterol Hepatol. 2019. PMID: 30957098 Free PMC article.
• Negative Regulation of Interferon-β Production by Alternative Splicing of Tumor Necrosis Factor Receptor-Associated Factor 3 in Ducks.
  Wei X, Qian W, Sizhu S, Li Y, Guo K, Jin M, Zhou H. Wei X, et al. Front Immunol. 2018 Mar 1;9:409. doi: 10.3389/fimmu.2018.00409. eCollection 2018. Front Immunol. 2018. PMID: 29599773 Free PMC article.

Publication types

MeSH terms

Substances

LinkOut - more resources

• Other Literature Sources

  • The Lens - Patent Citations Database